ID   GSC-326/ALDH1A3-KO.3.4
AC   CVCL_C6J8
DR   Wikidata; Q116049094
RX   PubMed=34934174;
CC   Group: Cancer stem cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 409; ALDH1A3.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
DI   NCIt; C4822; Malignant glioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C6IR ! GSC-326
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
RX   PubMed=34934174; DOI=10.1038/s42003-021-02949-7;
RA   Li J.-F., Garavaglia S., Ye Z.-F., Moretti A., Belyaeva O.V.,
RA   Beiser A., Ibrahim M., Wilk A., McClellan S., Klyuyeva A.V.,
RA   Goggans K.R., Kedishvili N.Y., Salter E.A., Wierzbicki A.,
RA   Migaud M.E., Mullett S.J., Yates N.A., Camacho C.J., Rizzi M.,
RA   Sobol R.W.;
RT   "A specific inhibitor of ALDH1A3 regulates retinoic acid biosynthesis
RT   in glioma stem cells.";
RL   Commun. Biol. 4:1420.1-1420.16(2021).
//